Please assess the completion status of the following clinical trial:

Trial Title: Eumycetoma Long-term Post-Treatment Follow-Up Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: RETROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Clinical trial participants who were previously enrolled and received investigational product (fosravuconazole) or standard of care treatment (itraconazole) in the DNDi-FOSR-04-MYC clinical trial.~2. In trial DNDi-FOSR-04-MYC had no recurrence of eumycetoma lesion before month 15.~3. Able and willing to give written informed consent for participation in this study, prior to performance of any study procedures.~Exclusion Criteria:~1. Any condition that, in the opinion of the Principal Investigator or designee, would preclude provision of informed consent or interfere with achieving the study objectives.

- Gender: ALL
- Minimum Age: 15 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).